Celldex Therapeutics, Inc. Shareholders' Equity
Celldex Therapeutics, Inc. (CLDX) had Shareholders' Equity of $714.56 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $714.56M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $456.23M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $527.16M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $598.36M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $714.56M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $456.23M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $527.16M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $598.36M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $655.41M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $702.98M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $747.00M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $785.90M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $813.66M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $838.61M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $429.17M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $246.72M 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $277.54M 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $302.74M 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $326.20M 10-K · filed 2026-02-25 | |
| 2022-09-30 | $345.42M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $365.09M 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $398.10M 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $419.48M 10-K · filed 2025-02-27 | |
| 2021-09-30 | $436.71M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $182.28M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $194.17M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $209.36M 10-K · filed 2024-02-26 | |
| 2020-09-30 | $229.97M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $238.44M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $83.70M 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $94.03M 10-K · filed 2023-02-28 | |
| 2019-09-30 | $101.38M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $109.63M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $112.69M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $124.06M 10-K · filed 2022-02-28 | |
| 2018-09-30 | $128.13M 10-Q · filed 2019-11-12 | $128.13M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $128.05M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $134.09M 10-Q · filed 2019-11-12 | $134.08M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $236.37M 10-K · filed 2021-03-29 | |
| 2017-09-30 | $219.15M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $231.46M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $247.84M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $265.43M 10-K · filed 2020-03-26 | |
| 2016-09-30 | $217.09M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $234.71M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $260.03M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $290.11M 10-K · filed 2019-03-07 | |
| 2015-09-30 | $318.63M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $345.88M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $375.55M 10-Q · filed 2015-04-29 | |
| 2014-12-31 | $211.66M 10-K · filed 2018-03-07 | |
| 2014-09-30 | $239.37M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $265.31M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $291.85M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $319.80M 10-K · filed 2017-03-14 | |
| 2013-09-30 | $156.75M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $177.09M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $194.94M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $95.77M 10-K/A · filed 2016-02-25 | |
| 2012-09-30 | $91.02M 10-Q · filed 2012-11-02 | |
| 2012-06-30 | $94.55M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $107.89M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $68.72M 10-K · filed 2015-02-24 | |
| 2011-09-30 | $80.67M 10-Q · filed 2011-11-03 | |
| 2010-12-31 | $75.25M 10-K · filed 2014-03-03 | |
| 2009-12-31 | $73.77M 10-K · filed 2013-03-08 | |
| 2008-12-31 | $18.13M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |